Two systems are currently used to serologically type Vibrio cholerae O1 and non-O1 isolates. Antiserovar-serotype serum in the Smith system is produced in rabbits immunized with live whole-cell vaccines, and that in the Sakazaki system is produced in rabbits immunized with heat-killed vaccines. In neither system is the serovar-serotype-specific antigen clearly defined. During the course of a serological survey, ca. 10% of more than 2,500 V. cholerae isolates examined agglutinated in the optimal dilutions of two, three, or four different anti-serovar sera prepared by the methods of Sakazaki. An occasional isolate agglutinated in both anti-O1 and non-O1 sera. Lipopolysaccharide was extracted from eight of these possible multiple serovars, coated onto rabbit erythrocytes, and retested in these same antisera by passive hemagglutination. With one exception the lipopolysaccharide-rabbit erythrocytes were now agglutinated in a single antiserum. Antipolysaccharide sera were produced in rabbits immunized with the polysaccharide moiety extracted from eight non-O1 and two O1 vaccine strains conjugated to bovine gamma globulin protein carrier. The antipolysaccharide sera showed passive hemagglutination titers versus lipopolysaccharide-rabbit erythrocytes comparable to those achieved in antisera from rabbits immunized with heat-killed whole-cell vaccines. In the slide agglutination test antipolysaccharide sera serologically discriminated between two O1 isolates that were previously agglutinated in both anti-O1 and anti-non-O1 whole-cell sera. It is recommended that serological types or varieties of V. cholerae non-O1 be based upon serologically recognizable differences in lipopolysaccharide-associated antigens as are antigens A, B, and C in the O1 group.
Presently, two systems are used to serologically discriminate Vibrio cholerae non-O1 serotypes. Sakazaki et al. (8) (9) (10) extended the number of serologically detectable V. cholerae 0-antigen groups from the 7 reported by Gardner and Venkatraman (2) to 60. The immunological procedures and serogroup numerical designations suggested by Gardner and Venkatraman were continued by Sakazaki, except that Sakazaki identifies 0-antigen groups in V. cholerae non-O1 as serological varieties (serovars) rather than O groups. A second typing system, developed by Smith (11, 12) , presently recognizes 72 serotypes, and the numerical designations assigned to non-O1 serotypes in this system were arrived at independently. The lack of correlation in serological nomenclature has caused considerable confusion when attempts are made for epidemiological reasons to translate a Sakazaki serovar into a Smith serotype or vice versa. Brenner et al. (1) attempted to correlate serovar and serotype designations in each system by testing the non-O1 vaccine strains from each collection in the typing sera of the opposite collection. Unfortunately, only 20 of the Sakazaki vaccine strains were found to be serologically identical to 20 in the Smith system, whereas 15 serovars and 13 serotypes, respectively, appeared to be unique to each system. The remaining vaccine strains in each system were agglutinated by two or more antisera in the opposite system, which made consistent correlations difficult.
Two reasons for the apparent lack of correlation between these serological nomenclatures originate with the disparities in the methods used by each investigator to prepare vaccines and immunization protocols. First, typing sera produced in rabbits immunized with live vaccines in the Smith system will potentially react with heat-labile antigens that antisera produced in rabbits immunized with heat-killed vaccines in the Sakazaki system will not. Second, Sakazaki uses a series of injections of the killed vibrios, in contrast to a single immunization which Smith uses, thereby increasing the chances of the production of antibodies in response to minor antigens. At the moment it appears that typing sera in each system may detect a serovar-serotype-specific antigen (yet to be defined); but these sera also contain serological activity directed against additional non-serovar-serotypespecific antigens, which accounts for the cross-reactions reported by Brenner et al. (1) . To reconcile the two systems, it is imperative that the serovar-serotype-specific antigen be defined.
The Kauffmann-White (4) scheme used to serologically group salmonella is predicated on the serological detection of polysaccharide (PS)-associated 0-antigens in the smooth core of lipopolysaccharide (LPS) in the outer membrane envelope. Similarly, serovar-serotype-specific antigens A, B, and C in V. cholerae O1 have been located serologically in the PS portion of the smooth core in LPS (5, 6) . Because of these precedents and for the sake of uniformity, it makes sense to serologically group V. cholerae non-O1 organisms based upon the detection of serovar-serotype-specific LPSassociated 0-antigens.
It is the intent of this communication to show that LPSassociated antigens unique to V. cholerae non-O1 vaccine strains are serologically detectable and that antisera specific for these LPS-associated antigens can be produced in rabbits immunized with PS-protein carrier conjugates.
MATERIALS AND METHODS
Vaccine strains. Typing sera. Antisera to V. cholerae O1 and non-O1 strains (Table 1) were produced in rabbits immunized with live vaccines prepared by the methods of Smith (11), heatkilled vaccines prepared by the methods of Sakazaki et al. (9) , and PS-protein carrier conjugates prepared from detoxified LPS conjugated to bovine gamma globulin (BGG).
Preparation of PS-BGG immunogen. LPS was extracted from 4 to 10 g of acetone-dried cells prepared from each of the V. cholerae vaccine strains by the method of Westphal and Jann (14) . Each LPS preparation (1 mg/ml) was detoxified in 0.25 N NaOH at 37°C for 4 h, followed by 1 h at 56°C.
Detoxified LPS was dialyzed against water overnight, and then the lipid was sedimented by centrifugation at 105,000 x g for 3 h. The supernatant fluid, PS 0-antigen, was lyophilized. To conjugate PS to BGG, 10 mg of PS was dissolved in 2 ml of 0.15 M H3 B03-0.5 M NaCI, pH 8.6. Next, 7 mg of CNBr crystals was added to the PS, and the solution was stirred for 15 min while the pH was maintained at 8.6. Activated PS was added to 10 ml of a 0.1% solution of BGG (Sigma Chemical Co., St. Louis, Mo.) in borate-sodium chloride buffer, and the coupling reaction was allowed to proceed, with stirring, overnight at 4°C. The PS-BGG conjugate was dialyzed against 0.067 M phosphate-buffered saline (PBS, pH 7.3) for 6 h and then against saline overnight. The PS-BGG preparation was concentrated to 5 ml, and 2.5 ml (ca. 5 mg of the conjugate) was emulsified in an equal volume of Freund adjuvant (Difco, Laboratories, Detroit, Mich.). Rabbits were immunized by injecting 0.5 ml of the PS-BGG adjuvant intramuscularly into each hindquarter and in 7 to 10 sites subcutaneously along the spine and the nuchal region. The animals received a second immunization 30 days later of 2.5 ml of PS-BGG incorporated into incomplete adjuvant.
Serology. Antibody activity in each preparation of anti-V. cholerae serum was tested by both slide agglutination and passive hemagglutination (PHA). V. cholerae cells harvested in PBS or 0.3% formolized PBS from a 24-h slant were mixed with various dilutions of each antiserum on a glass slide and examined over a 1-min period for evidence of agglutination. The PHA test was used to test each O1 and non-O1 antiserum for anti-PS activity by the addition of LPSsensitized rabbit erythrocytes (RRBC) to dilutions of each antiserum. LPS was extracted from environmental and vaccine strains. Before RRBC were sensitized, LPS was treated with 0.02 N NaOH (1 mg/ml) for 5 h at 37°C and then neutralized in 19 volumes of PBS. To a 5% suspension of RRBC washed three times (in PBS) was added an equal volume of alkaline-treated LPS (50 ,ug/ml), and the suspension was incubated for 2 h at 37°C. LPS-sensitized RRBC were washed three times in PBS and resuspended to 0.5% (vol/vol) in PBS. Serial dilutions of heat-inactivated antiserum were made in PBS, and an equal volume of LPSsensitized RRBC was added to each tube. Agglutination patterns were examined after 90 min at 37°C, and titers were determined after overnight incubation at 4°C.
RESULTS
Over a 3-year period, more than 2,500 environmental V. cholerae isolates were examined serologically by slide agglutination in antisera raised in rabbits immunized with heatkilled vaccines prepared from 46 different V. cholerae non-O1 serovars (7) . Three hundred of the environmental isolates were agglutinated in the optimal dilutions of two or more of the anti-serovar sera. Table 2 ). These three isolates were also agglutinated in optimal dilutions of anti-FF and in low dilutions of anti-O and anti-X sera. Do these findings imply that O1 and non-O1 serovar-serotype-specific antigens are coexpressed in V. cholerae isolates, or are different classes of 0-antigens being detected? If La 8584 is an O1 serovar, then anti-XX serum is reacting with either group-specific O1 LPS-associated antigen A, B, or C or with a non-LPS-associated antigen.
Since serovar-specific O1 antigens A, B, and C are structural components of LPS (5, 6), it would be logical to serologically group V. cholerae non-O1 isolates through serologically unique LPS-associated antigens. To determine whether isolate La 8584 exhibits O1 antigens A, B, and C and non-O1 antigen XX in LPS, this cell wall component was extracted from each of the eight environmental isolates, coated onto RRBC, and retested by PHA in the same 10 antisera. Table 3 shows the PHA titers of antisera produced against heat-killed whole-cell vaccines and tested against The implication is that La 8584 is a V. cholerae O1 serovar. La 9214 LPS-sensitized RRBC were also agglutinated in anti-Ol serum only.
Isolates La 9296, La 9313, and La 9302 appear to be V. cholerae non-O1 serovar XX since LPS extracted from these organisms exhibited elevated PHA titers in anti-XX serum, with no reaction in anti-O or anti-FF serum, but showed lowlevel activity in anti-X serum (Table 3) . Isolate La 6169 does not appear to be serotype Q or Y but some yet to be identified serovar; however, the validity of this interpretation should be questioned based upon the extremely low yield of LPS extracted from this isolate. It is possible that RRBC were not optimally sensitized with La 6169 LPS, if at all. It appears that typing sera raised in rabbits immunized with heat-killed vaccines possess serovar-specific anti-LPS activity if the serovar-specific antigen is defined as LPS; and some typing sera also possess high levels of antibody activity to a yet to be defined heat-stable, non-LPS antigen shared among serogroups.
When a V. cholerae isolate is agglutinated in two or more anti-serovar-sera, it is not expedient to extract LPS to ascertain by PHA the serological type or variety. Rather, serovar-specific (anti-LPS) typing sera are required. With this objective in mind, rabbits were immunized with PS-BGG conjugates to produce LPS-specific typing sera. PS-BGG conjugates were prepared from LPS extracted from the eight non-O1 vaccine strains (Table 1 ) and V. cholerae O1 (La 5875 and CA 411). Figure 1 compares the anti-LPS antibody responses in representative rabbits immunized with a live vaccine, a heat-killed whole-cell vaccine, or PS-BGG conjugate prepared from V. cholerae O1 Inaba (La 5875) and Ogawa (CA 411). Fifty percent of the rabbits immunized with live O1 or non-O1 vaccines died by days 3 to 4 postimmunization. Those that survived showed low levels of anti-PS (1:80) at the time of exsanguination on day 14. Smith (11) collects typing sera from rabbits 10 to 14 days after the ( LPS of each isolate was tested in antisera raised in rabbits Polysaccharide was used as an immunogeni to produce a irhmunized with heat-killed whole-cell vaccines (Table 3) . high-titer antiserum to the PS 0-antigen in the Vibrio cell
The single exception was La 6169, which agglutinated in wall which would bè serologically reactive with only those anti-PS serovar Q. The anti-LPS PHA titers (Table 4 ) imply vibrios which express that 0-antigen determinant. To assess that vaccine strains X and XX share at least one LPS the serological specificity of each anti-PS serum produced antigen, a finding substantiated in environmental isolates.
against the eight non-O1 serovars and two Pi strains, the The anti-PS sera provide a level of specificity in slide titers of these sera were determined by PHA in a checkeragglutination comparable to that of the PHA test, which board fashion (Table 4) . improves upon the presently used typing sera produced in the PHA titers suggest that each of the eight non-O1 rabbits immunized with whole-cell vaccines.
vaccine strains possesses a unique (serovar-specific) LPSassociated antigen. In addition, either vaccine strains O and DISCUSSION Q share a second minor LPS antigen, or each vaccine strait It was not our intention to add a third serological typing expresses the Q-and 0-antigen, respectively, at a low scheme and its inherent nomenclature to the two systems concentration. Vaccine strain XX probably expresses antipresently in use (9, 11) . The typing serum we have used to gen X, whereas strain X does not express detectable levels serologically examine thousands of environmental V. choof antigen XX. When a similar serological checkerboard lerae isolates (7) was prepared by using the methods of titration was done by testing the anti-PS sera with livé cell Sakazaki (9) . It became apparent that typing sera raised in suspensions of the vaccine strains by slide agglutination, an rabbits immunized with heat-killed whole-cell vaccines did identical result pattern was seen. not possess the specificity necessary to serologically dis-
The eight environmental isolates were retested by slide criminate between non-O1 serotypes and serovars (Table 2) . agglutination in each of the 10 anti-PS sera (Table 5 ). Isolate One plausible explanation for the apparent lack of correlaLa 8584 had agglutinated in both anti-non-O1 XX serum and tion between the two currently used serological typing anti-O1 serum produced in rabbits immunized with heatschemes originates with the disparity in the methods used to One approach that could be followed to unify the serological nomenclature used to identify V. cholerae non-01 groups (serovars-serotypes) could bp done in the following manner.
LPS, if it is agreed that the serovar-specific antigen resides in this cell wall constituent, could be extracted from the vaccine strains of either the Smith or the Sakazaki collection. RBC coated with LPS would be tested by PHA with the homologous and heterologous typing sera in that collection. In this manner the minimum, number of unique LPS-associated antigens in the collection can be serologically identified.
Determinants that may be shared among serovars, in the manner that the A-determinant is shared by the Inaba, Ogawa, and Hikojima serovars in the O1 group, may be identified. Next, the typing serum in the opposite collection would be used to serologically test the LPS-sensitized RBC in an attempt to identify its counterpart in the first collection. In addition, serogroups unique to each collection would be recognized, a finding reported by Brenner et al. (1) .
